Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Activity”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Study completedNCT00000421
What this trial is testing

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 154
Not applicableStudy completedNCT00340665
What this trial is testing

Study of Infant Diets on Estrogen Activity and Development

Who this might be right for
Infant FormulaEstrogen Activity
National Institute of Environmental Health Sciences (NIEHS) 239
Large-scale testing (Phase 3)Study completedNCT00745108
What this trial is testing

Tibolone Endometrium Study (Study 32972)(P06470)

Who this might be right for
Postmenopausal Women
Organon and Co 32
Testing effectiveness (Phase 2)Study completedNCT03585712
What this trial is testing

Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill

Who this might be right for
Contraception
HRA Pharma 52
Not applicableStudy completedNCT01120665
What this trial is testing

Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women

Who this might be right for
Women's Health
University of Sao Paulo General Hospital 62
Large-scale testing (Phase 3)Looking for participantsNCT07085767
What this trial is testing

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast CancerMetastatic Breast Cancer+2 more
Olema Pharmaceuticals, Inc. 1,000
Early research (Phase 1)Study completedNCT02248090
What this trial is testing

AZD9496 First Time in Patients Ascending Dose Study

Who this might be right for
ER+ HER2- Advanced Breast Cancer
AstraZeneca 45
Early research (Phase 1)Active Not RecruitingNCT03332797
What this trial is testing

GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 181
Early research (Phase 1)Study completedNCT02684032
What this trial is testing

Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Celcuity Inc 141
Testing effectiveness (Phase 2)Study completedNCT00420342
What this trial is testing

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Who this might be right for
PostmenopauseHypertensionPre-Hypertension
Bayer 92
Not applicableStudy completedNCT02057536
What this trial is testing

The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.

Who this might be right for
Women With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and Stiffness
Christiana Care Health Services 30
Early research (Phase 1)Looking for participantsNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 48
Not applicableStudy completedNCT00100451
What this trial is testing

Aging, Exercise, and Hormonal Influences of Fat Metabolism

Who this might be right for
Cardiovascular Disease
US Department of Veterans Affairs
Large-scale testing (Phase 3)Study completedNCT00675688
What this trial is testing

Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Who this might be right for
Endometrial HyperplasiaOsteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 3,544
Early research (Phase 1)Looking for participantsNCT07318805
What this trial is testing

Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Breast CancerMetastatic Breast Cancer (HR+/ HER2-)Colorectal Cancer+2 more
Pfizer 260
Not applicableNot Yet RecruitingNCT07212712
What this trial is testing

The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

Who this might be right for
Cerebral Blood FlowCerebral Blood Flow RegulationSex Differences+2 more
University of British Columbia 50
Large-scale testing (Phase 3)Study completedNCT00808132
What this trial is testing

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Who this might be right for
MenopauseOsteoporosis
Pfizer 1,886
Not applicableStudy completedNCT03523195
What this trial is testing

Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+16 more
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT00342095
What this trial is testing

Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Environmental Health Sciences (NIEHS) 640
Early research (Phase 1)Study completedNCT03455270
What this trial is testing

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Who this might be right for
Carcinoma, Ductal, BreastBreast Cancer FemaleBreast Neoplasm+4 more
G1 Therapeutics, Inc. 107
Load More Results